Centro de Referencia Estatal de Atención Al Daño Cerebral
5
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Safety and Usability of the STELO Exoskeleton in People With Acquired Brain Injury and Spinal Cord Injury
Role: collaborator
Cross-cultural Adaptation to the Spanish Population and Validation of the Community Balance & Mobility Scale (S-CB&M)
Role: collaborator
Cross-cultural Adaptation to the Spanish Population and Validation of the BESTest and Mini-BESTest
Role: lead
Clinical Effectiveness of the ReHand App in Hand Rehabilitation After Stroke
Role: collaborator
Therapy to Improve Reaching Movement in Upper Limb
Role: collaborator
All 5 trials loaded